Drugs for Swallowing Disorders (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 143)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Remifentanil |
Approved |
Phase 4 |
|
132875-61-7 |
60815 |
Synonyms:
3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
GI 87084X
GI-87084B
IDS-NR-005
Remifentanil
|
Remifentanil hydrochloride
Remifentanil monohydrochloride
Remifentanilo
Remifentanyl
Ultiva
|
|
2 |
|
Acetaminophen |
Approved |
Phase 4 |
|
103-90-2 |
1983 |
Synonyms:
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4'-Hydroxyacetanilide
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
A.F. anacin
ABDINE
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-tap
Acenol
Acephen
Acertol
Aceta elixir
Aceta tablets
Acetaco
Acetagesic
Acetalgin
Acetamidophenol
Acetaminofen
ACETAMINOFÉN
ACETAMINOPHEN
Acetaminophen uniserts
acetaminophen|Panadol®|Tylenol®
Acetaminophene
ACÉTAMINOPHÈNE
Acetamol
Acetofen
Acetominophen
Actamin
Actamin extra
Actamin super
Actifed plus
Actimol
Actimol chewable tablets
Actimol children's suspension
Actimol infants' suspension
Actimol junior strength caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
alpha-Per
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen max
Anacin
Anacin 3
Anacin3
Anacin-3
Anacin-3 extra strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
ANGIERS
Anhiba
Anoquan
Anti-algos
Antidol
Apacet
Apacet capsules
Apacet elixir
Apacet extra strength caplets
Apacet extra strength tablets
Apacet regular strength tablets
Apadon
Apamid
Apamide
APAP
a-Per
Apitrelal
Apo-acetaminophen
Arfen
Asetam
Asomal
Aspac
Aspirin free anacin maximum strength caplets
Aspirin free anacin maximum strength gel caplets
Aspirin free anacin maximum strength tablets
Aspirin-free anacin
Aspirin-free excedrin caplets
Asplin
Atasol
Atasol caplets
Atasol drops
Atasol forte caplets
Atasol forte tablets
Atasol oral solution
Atasol tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap HC
Banesin
Bayer Select
Bayer select allergy-sinus
Bayer select head cold
Bayer select headache pain
Bayer select maximum strength headache pain relief formula
Bayer select menstrual multi-symptom
Bayer select sinus pain relief
Benmyo
Ben-u-ron
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
Cadafen
Calapol
Calmanticold
Calpol
CALPOL SIX PLUS
CALPOL SIX PLUS FASTMELTS
Capital with codeine
Captin
Causalon
Cefalex
Cetadol
CHILD LEMSIP
Children'S acetaminophen elixir drops
Children'S acetaminophen oral solution
Children'S tylenol chewable
Claradol codeine
Clixodyne
Codabrol
COD-Acamol forte
Codalgin
Codapane
Codicet
Codisal
Codisal forte
Codoliprane
Codral pain relief
Cofamol
CO-Gesic
Conacetol
Contac cough & sore throat formula
Contra-schmerz p
Coricidin
Coricidin D
Coricidin sinus
Cosutone
Croix blanche
CUPANOL
Cuponol
Curadon
Curpol
Custodial
DAFALGAN
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril extra-strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
DHC Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
DISPROL INFANT
DISPROL JNR
DISPROL PAED
Dolcor
Dolefin
Dolegrippin
Dolene ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol forte
Dolorstop
Dolotec
Dolprone
Dol-stop
Dorocoff
Dresan
Dristan cold no drowsiness
Dristancito
Drixoral Plus
Dularin
Duracetamol
Duradyne DHC
Durapan
Dymadon
Dymadon co
Dymadon forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-plus
Eu-med
Excedrin
Excedrin caplets
Excedrin extra strength caplets
Excipain
Exdol
Exdol strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-gesic
Febrolin
Femcet
Fendon
FENNINGS
Fensum
Fepanil
Feverall
Feverall junior strength
Feverall sprinkle caps junior strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon p
Freka-cetamol
GALPAMOL
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap children's elixir
Genapap children's tablets
Genapap extra strength caplets
Genapap extra strength tablets
Genapap regular strength tablets
Genebs
Genebs extra strength caplets
Genebs regular strength tablets
Genebs X-tra
Geralgine-p
Gripin bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hycomine compound
Hydrocet
Hydroxyacetanilide
Hy-phen
Ildamol
Inalgex
Infadrops
Infants' feverall
Influbene N
Injectapap
Intensin
Janupap
Junior disprol
JUNIOR PARAPAED
Kataprin
Kinder finimal
Korum
Kratofin simplex
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liquagesic
Liquigesic co
Liquiprin
Liquiprin children's elixir
Liquiprin infants" drops
Lonarid
Lonarid mono
Lorcet-HD
Lortab
Lupocet
Lyteca
Lyteca syrup
Magnidol
Malex N
Malgis
Malidens
MANDANOL
Maxadol
Medigesic plus
MEDINOL
MEDINOL FOR CHILDREN
MEDINOL OVER 6
Medinol paediatric
MEDINOL UNDER 6
MEDISED PLAIN
Medocodene
Melabon infantil
Mexalen
Midol maximum strength
Midol PM night time formula
Midol regular strength
Midol teen formula
Migraleve yellow
Minafen
Minoset
MIRADOL
Miralgin
Momentum
|
mono Praecimed
Multin
N-(4-Hydroxyphenyl)acetamide
N-(4-Hydroxyphenyl)acetanilide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
Naldegesic
NAPA
Napafen
Napap
Naprinol
Nealgyl
Nebs
NeoCitran
Neodol
Neodolito
Neo-fepramol
Neopap
Neotrend
Neuridon
New cortal for children
NilnOcen
Nina
Nobedon
Nodolex
NO-Febril
Noral
Norcet
Norco
NSC-109028
NSC-3991
O-Acetaminophenol
OFIRMEV
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/apap 500
Oxycodone 5/apap 500
p-(Acetylamino)phenol
Paceco
Pacemo
Pacemol
Pacet
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine co
Panadiene
PANADO
Panado-co
Panado-co caplets
Panadol
PANADOL ACTIFAST
PANADOL ACTIFAST SOLB
PANADOL ADVAN
Panadol extra strength
PANADOL JNR
Panadol junior strength caplets
Panadol maximum strength caplets
Panadol maximum strength tablets
PANADOL OA
Panaleve
PANALEVE 6 PLUS
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-deine #3
Papa-deine #4
Paracemol
Paracenol
Paracet
Paracetamol
PARACÉTAMOL
Paracetamol al
Paracetamol antipanin p
Paracetamol basics
Paracetamol BC
Paracetamol DC
Paracetamol dr. schmidgall
Paracetamol fecofar
Paracetamol genericon
Paracetamol hanseler
Paracetamol harkley
Paracetamol heumann
Paracetamol hexal
Paracetamol italfarmaco
Paracetamol nycomed
Paracetamol PB
Paracetamol raffo
Paracetamol ratiopharm
Paracetamol rosch
Paracetamol saar
Paracetamol smithkline beecham
Paracetamol stada
Paracetamol von CT
Paracetamol winthrop
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
PARAMIN
Paramol
Paramolan
Paranox
PARAPAED JNR
PARAPAED SIX PLUS
Parapan
Parasedol
Parasin
Paraspen
Para-suppo
Para-tabs
PARAVICT
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
PCM Paracetamol lichtenstein
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-demi
Percogesic with codeine
Perdolan mono
PERFALGAN
Pe-tam
Phenaphen
Phenaphen caplets
Phenaphen w/codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin forte
P-HYDROXY-ACETANILID
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
Pinex
Piramin
Pirinasol
PLACIDEX
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet world
Redutemp
Reliv
Remedol
Rhinex D-lay tablets
RIMADOL
Rivalgyl
Robigesic
Robitussin night relief
Rockamol plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sinedol
Sine-OFF sinus medicine caplets
Sinmol
Sinubid
SK-Apap
Snaplets-FR
Spalt fur die nacht
Spalt N
ST Joseph aspirin-free
ST Joseph aspirin-free for children
St. joseph cold tablets for children
St. joseph fever reducer
Stanback
Stopain
Sudafed severe cold formula
Sudafed sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-m
Synalgos-DC-a
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol extra strength caplets
Tapanol extra strength tablets
Tapar
Tavist allergy/sinus/headache
Tazamol
Temlo
Tempanal
Tempra
Tempra caplets
Tempra chewable tablets
Tempra d.s
Tempra drops
Tempra syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
TIXYMOL
Tizide
Tocris-1706
Toximer p
Tralgon
TRAMIL 500
Treupel mon
Treupel N
Treuphadol
Triad
Triaminic sore throat formula
Triaprin
Tricoton
Tussapap
Tycolet
TYL
Tylenol
Tylenol allergy sinus
Tylenol arthritis extended relief
Tylenol caplets
Tylenol children's chewable tablets
Tylenol children's elixir
Tylenol children's suspension liquid
Tylenol drops
Tylenol elixir
Tylenol extra strength adult liquid pain reliever
Tylenol extra strength caplets
Tylenol extra strength gelcaps
Tylenol extra strength tablets
Tylenol gelcaps
Tylenol infants drops
Tylenol infants" suspension drops
Tylenol junior strength caplets
Tylenol junior strength chewable tablets
Tylenol regular strength caplets
Tylenol regular strength tablets
Tylenol tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor richet
Vicodin
Vicodin es
Vicodin HP
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
|
|
3 |
|
Buspirone |
Approved, Investigational |
Phase 4 |
|
36505-84-7 |
2477 |
Synonyms:
8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione
Anxut
Apo buspirone
Apo-buspirone
Apotex brand OF buspirone hydrochloride
Armstrong brand OF buspirone hydrochloride
BCI-024
Bespar
Bristol myers brand OF buspirone hydrochloride
Bristol myers squibb brand OF buspirone hydrochloride
Bristol-myers brand OF buspirone hydrochloride
Bristol-myers squibb brand OF buspirone hydrochloride
Busp
Buspar
Buspar®|MJ-9022-1
Buspiron
Buspirona
Buspirone
Buspirone hydrochloride
Buspironum
Eisai brand OF buspirone hydrochloride
Gen buspirone
Gen-buspirone
Genpharm brand OF buspirone
|
Hexal brand OF buspirone hydrochloride
Hormosan brand OF buspirone hydrochloride
Hydrochloride, buspirone
Lin buspirone
Lin-buspirone
Linson pharma brand OF buspirone hydrochloride
MJ-9022-1
N-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide
Neurosine
Novo buspirone
Novo-buspirone
Novopharm brand OF buspirone hydrochloride
Nu buspirone
Nu pharm brand OF buspirone hydrochloride
Nu-buspirone
Nu-pharm brand OF buspirone hydrochloride
Pharmascience brand OF buspirone hydrochloride
PMS Buspirone
PMS-Buspirone
Ratio buspirone
Ratio-buspirone
Ratiopharm brand OF buspirone hydrochloride
UPSA brand OF buspirone hydrochloride
|
|
4 |
|
Oxycodone |
Approved, Illicit, Investigational |
Phase 4 |
|
76-42-6 |
5284603 |
Synonyms:
(-)-14-Hydroxydihydrocodeinone
4,5a-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
4,5Α-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
Combunox
Dihydro-14-hydroxycodeinone
Dihydrohydroxycodeinone
Dihydrohydroxycondeinone
Dihydrone
Dihydroxycodeinone
Dinarkon
Diphydrone
Endocet
Endodan
Endone
Eubine
Eucodal
Eucodalum
Eukodal
Eutagen
IDS-NO-002
N02AA05
NSC-19043
Oxanest
Oxicodona
Oxicodona [INN-Spanish]
Oxicon
OXICONE
Oxiconum
Oxikon
Oxycodeinon
|
Oxycodeinone
Oxycodon
OXYCODONE
OXYCODONE CII
Oxycodone Hcl
Oxycodone hydrochloride
Oxycodonum
Oxycodonum [INN-Latin]
Oxycon
Oxycone
Oxycontin
OxyFAST
OxyIR
OxyNorm
Pancodine
Percobarb
Percodan
Percolone
PF-00345439
PROLADONE
PTI-821
Purdue frederick brand OF oxycodone
Remoxy
ROXICODONE
Supendol
Supeudol
Tecodin
Tekodin
Thecodine
Thekodin
Theocodin
XTAMPZA ER
|
|
5 |
|
Lisinopril |
Approved, Investigational |
Phase 4 |
|
83915-83-7, 76547-98-3 |
5362119 |
Synonyms:
(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline
Acerbon
Acercomp
Alapril
Carace
Cipral
Cipril
Coric
Inhibril
Inopril
Linopril
Linvas
Lipril
Lisinal
LISINOPRIL
Lisinopril anhydrous
LISINOPRIL DIHYDRATE
LISINOPRIL HYDRATE
Lisinopril maleate (1:1)
Lisinopril sulfate (1:2)
Lisinoprilum
Lisipril
|
Lisoril
Lispril
Loril
LPR
Lysinopril
MK-521
Noperten
Novatec
Presiten
Prinil
Prinivil
Prinivil®|Zestril®
Prinzide
Renacor
Sinopril
Sinopryl
Tensopril
Tensyn
Tersif
Vivatec
Zestoretic
Zestril
|
|
6 |
|
Analgesics |
|
Phase 4 |
|
|
|
7 |
|
Antipyretics |
|
Phase 4 |
|
|
|
8 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
9 |
|
Carboxymethylcellulose Sodium |
|
Phase 4 |
|
|
|
10 |
|
Serotonin Receptor Agonists |
|
Phase 4 |
|
|
|
11 |
|
HIV Protease Inhibitors |
|
Phase 4 |
|
|
|
12 |
|
protease inhibitors |
|
Phase 4 |
|
|
|
Synonyms:
|
13 |
|
Protective Agents |
|
Phase 4 |
|
|
|
14 |
|
Cardiotonic Agents |
|
Phase 4 |
|
|
|
15 |
|
Antihypertensive Agents |
|
Phase 4 |
|
|
|
16 |
|
Angiotensin-Converting Enzyme Inhibitors |
|
Phase 4 |
|
|
|
17 |
|
Rabeprazole |
Approved, Investigational |
Phase 2, Phase 3 |
|
117976-89-3, 117976-90-6 |
5029 |
Synonyms:
1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt
2-((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole
Aciphex
ACIPHEX SPRINKLE
Clofezone
Dexrabeprazole
E3810
E-3810
E-3810 (PPI)
E-3810 SODIUM
Eraloc
Habeprazole
Irsogladine Maleate
|
LY307640
LY-307640
LY307640 SODIUM
LY-307640 SODIUM
Pariet
Pariets
RABEPRAZOLE
Rabeprazole sodium
RABEPRAZOLE SODIUM SALT
Rebeprazole sodium
Sodium rabeprazole
Sodium, rabeprazole
|
|
18 |
|
Cisplatin |
Approved |
Phase 3 |
|
15663-27-1 |
2767 5702198 441203 |
Synonyms:
Abiplatin
Biocisplatinum
Briplatin
CACP
Carboquone
CDDP
Cis Pt II
cis-DDP
Cis-Diaminedichloroplatinum
Cis-Diamminedichloroplatinum
CIS-DIAMMINEDICHLOROPLATINUM(II)
Cismaplat
CISPLATIN
Cisplatine
cisplatino
CISPLATINUM
CIS-PLATINUM II
Cisplatyl
Citoplationo
CPDC
CPDD
DDP
DDPT
|
Diamminedichloroplatinum
INT230-6 COMPONENT CISPLATIN
INT-230-6 COMPONENT CISPLATIN
Lederplatin
Neoplatin
NSC-119875
Plastin
Platamine
Platiblastin
Platidiam
Platinex
PLATINOL
PLATINOL-AQ
Platinoxan
Platinum Ammine Chloride
Platinum Ammonium Chloride
Platinum Diamine Dichloride
Randa
trans-DDP
Trans-Diaminedichloroplatinum
Trans-Diamminedichloroplatinum
Trans-Dichlorodiammine Platinum
Trans-Platinumdiammine Dichloride
|
|
19 |
|
Zinc cation |
Approved, Experimental, Investigational |
Phase 3 |
|
7440-66-6, 23713-49-7 |
32051 |
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
Mannosidase b, alpha
Neutral alpha mannosidase
|
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc ion(2+)
Zinc(2+)
Zinc(II)
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
zinc|zinc ion
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
20 |
|
Fluorouracil |
Approved |
Phase 3 |
|
51-21-8 |
3385 |
Synonyms:
5 Fluorouracil
5 Fluorouracil biosyn
5 FU
5 FU lederle
5 FU medac
5 HU hexal
5.F.U.
5-Fluoracil
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluracil
5FU
5-FU
5-FU lederle
5-FU medac
5-HU hexal
ACCUSITE
ACTIKERALL
Adrucil
Allergan brand OF fluorouracil
Arumel
Biosyn brand OF fluorouracil
Carac
Carzonal
CSP Brand OF fluorouracil
Dakota brand OF fluorouracil
Dakota, fluorouracile
Dermatech brand OF fluorouracil
Dermik brand OF fluorouracil
Effluderm
Efudex
Efudix
Efurix
Ferrer brand OF fluorouracil
Fluoro Uracil
Fluoro uracile icn
Fluoroblastin
Fluoroplex
Fluorouracil
Fluorouracil gry
Fluorouracil mononitrate
Fluorouracil monopotassium salt
Fluorouracil monosodium salt
Fluorouracil potassium salt
FLUORO-URACIL ROCHE
Fluorouracil teva brand
|
Fluorouracile dakota
Fluoro-uracile icn
Fluorouracil-gry
Fluorouracilo
Fluorouracilo ferrer far
Fluorouracilum
Fluoruracil
Fluouracil
Fluracedyl
FLURACIL
Fluracilum
Fluri
Fluril
Fluro Uracil
Flurodex
Flurouracil
Ftoruracil
FU
Gry brand OF fluorouracil
Haemato brand OF fluorouracil
Haemato fu
Haemato-fu
Hexal brand OF fluorouracil
ICN brand OF fluorouracil
Kecimeton
Medac brand OF fluorouracil
Neocorp brand OF fluorouracil
Neofluor
NSC-19893
Onkofluor
Onkoworks brand OF fluorouracil
Pharmachemie brand OF fluorouracil monosodium salt
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Ribosepharm brand OF fluorouracil
Riemser brand OF fluorouracil
RO-29757
RO-2-9757
Roche brand OF fluorouracil
Teva brand OF fluorouracil
Timazin
TOLAK
Ulup
URF
|
|
21 |
|
Ketorolac |
Approved |
Phase 3 |
|
74103-06-3, 66635-83-4 |
3826 |
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
ACULAR
Acular LS
Acular Preservative Free
Acular®|Toradol®
Ketoralac
Ketorolac
|
Kétorolac
Ketorolac tromethamine
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
rac-Ketorolac
Toradol
|
|
22 |
|
Acetylcholine |
Approved, Investigational |
Phase 2, Phase 3 |
|
51-84-3 |
187 |
Synonyms:
[2-(ACETYLOXY)ETHYL]TRIMETHYLAZANIUM
2-(Acetyloxy)-N,N,N-trimethylethanaminium
2-ACETOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AZANIUM
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
ACETYLCHOLINE, ACH
Acetylcholinium: acetyl-choline
|
ACh
ACh|E1001|O-acetylcholine
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
E1001
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
23 |
|
Nicergoline |
Approved, Investigational |
Phase 3 |
|
27848-84-6 |
34040 |
Synonyms:
(8BETA)-10-METHOXY-1,6-DIMETHYLERGOLINE-8-METHANOL 5-BROMO-3-PYRIDINECARBOXYLATE (ESTER)
(8β)-10-methoxy-1,6-dimethylergoline-8-methanol 5-bromo-3-pyridinecarboxylate (ester)
10-METHOXY-1,6-DIMETHYLERGOLINE-8BETA-METHANOL 5-BROMONICOTINATE
10-methoxy-1,6-dimethylergoline-8β-methanol 5-bromonicotinate
Aventis brand OF nicergoline
Betapharm brand OF nicergoline
Circo maren
Circo-maren
CT Arzneimittel brand OF nicergoline
CT-Arzneimittel brand OF nicergoline
Dexcel brand OF nicergoline
Ergobel
F.I. 6714
FI-6714
Fisifax
Hexal brand OF nicergoline
Hormosan brand OF nicergoline
Kenfarma brand OF nicergoline
Krewel brand OF nicergoline
Lindopharm brand OF nicergoline
Neuraxpharm brand OF nicergoline
Nicergobeta
NICERGOLIN
Nicergolin atid
|
Nicergolin lindo
Nicergolin neuraxpharm
Nicergolin ratiopharm
Nicergolin teva
Nicergolin von CT
NICERGOLINA
NICERGOLINE
Nicergoline hexal brand
Nicergoline pfizer brand
Nicergoline teva brand
Nicergolin-neuraxpharm
Nicergolin-ratiopharm
Nicergolin-teva
NICERGOLINUM
Nicerium
Nicotergoline
Nimergoline
NSC-150531
Pfizer brand OF nicergoline
Ratiopharm brand OF nicergoline
Reig jofre brand OF nicergoline
Sermion
Teva brand OF nicergoline
Von CT, nicergolin
|
|
24 |
|
Carnosine |
Experimental, Investigational |
Phase 3 |
|
305-84-0, 107667-60-7 |
439224 |
Synonyms:
b-Alanylhistidine
b-Alanyl-L-histidine
beta Alanylhistidine
beta-Alanylhistidine
beta-Alanyl-L-histidinato zinc
beta-Alanyl-L-histidine
CARNOSINE
Carnosine hydrochloride
Carnosine, (D-his)-isomer
Hydrochloride, carnosine
Ignotine
Karnozin
Karnozzn
L Carnosine
|
L-Carnosine
N-(3-Aminopropanoyl)histidine
N-(b-Alanyl)-L-histidine
Nalpha-(b-alanyl)-L-histidine
Nalpha-(beta-alanyl)-L-histidine
Nalpha-(β-alanyl)-L-histidine
N-b-Alanyl-L-histidine
N-beta-Alanyl-L-histidine
POLAPREZINC
Sevitin
Z 103
Z-103
Zinc L-carnosine
|
|
25 |
|
Antimetabolites |
|
Phase 3 |
|
|
|
26 |
|
Immunosuppressive Agents |
|
Phase 3 |
|
|
|
27 |
|
Immunologic Factors |
|
Phase 3 |
|
|
|
28 |
|
Antirheumatic Agents |
|
Phase 3 |
|
|
|
29 |
|
Cyclooxygenase Inhibitors |
|
Phase 3 |
|
|
|
30 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 3 |
|
|
|
31 |
|
Adrenergic Agents |
|
Phase 3 |
|
|
|
32 |
|
abobotulinumtoxinA |
|
Phase 2, Phase 3 |
|
|
|
Synonyms:
ABOBOTULINUMTOXINA
BONT/A
BONTOXILYSIN A
BOTOX
BOTULINUM TOXIN TYPE A
|
BOTULINUM TOXINS, TYPE A
BOTULOTOXIN A
BTX-A
ONABOTULINUMTOXINA
|
|
33 |
|
Botulinum Toxins, Type A |
|
Phase 2, Phase 3 |
|
|
|
34 |
|
Botulinum Toxins |
|
Phase 2, Phase 3 |
|
|
|
35 |
|
Cholinergic Agents |
|
Phase 2, Phase 3 |
|
|
|
36 |
|
Adrenergic Antagonists |
|
Phase 3 |
|
|
|
37 |
|
Adrenergic alpha-Antagonists |
|
Phase 3 |
|
|
|
38 |
|
Vasodilator Agents |
|
Phase 3 |
|
|
|
39 |
|
Nootropic Agents |
|
Phase 3 |
|
|
|
40 |
|
Menthol |
Approved, Experimental |
Phase 2 |
|
1490-04-6, 2216-51-5, 15356-60-2 |
1254 16666 165675 |
Synonyms:
(−)-(1R,3R,4S)-menthol
(-)-(1R,3R,4S)-Menthol
(−)-menthol
(-)-Menthol
(-)-Menthyl alcohol
(-)-trans-p-Menthan-cis-ol
(+)-(1S,2R,5S)-menthol
(+)-(1S,3S,4R)-menthol
(+-)-Menthol
(1a,2b,5a)-5-Methyl-2(1-methylethyl)cyclohexanol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1R-(1-a,2-b,5-a))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1R-(1-Α,2-β,5-α))-5-methyl-2-(1-methylethyl)cyclohexanol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-Menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(−)-menthol
(1R,3R,4S)-(-)-Menthol
(1S,2R,5S)-(+)-menthol
(1S,2R,5S)-menthol
(1Α,2β,5α)-5-methyl-2(1-methylethyl)cyclohexanol
(R)-(-)-Menthol
1-Menthol
1-Methyl-4-isopropyl-3-hydroxycyclohexane
2-Isopropyl-5-methylcyclohexanol
3-Hydroxy-P-menthane
3-P-Menthanol
3-P-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-propan-2-ylcyclohexan-1-ol
AQUA-COOL
AQUASOOTHE
ARJUN
CATARRH
|
D-(-)-Menthol
DERMACOOL
DL-menthol
D-menthol
FEMA NO. 2665
Fisherman's friend lozenges
HALLS
Hexahydrothymol
KARVOL
Kerasal
L-(-)-Menthol
Levomenthol
Lévomenthol
Levomentholum
Levomentol
L-Menthol
l-menthol|levomenthol
LOCKETS
MEGGEZONES
Menthacamphor
Menthol
Menthol natural
Menthol racemic
Menthol racemique
Menthol, (1alpha,2beta,5alpha)-isomer
Menthomenthol
Mentol
MUIRS
Peppermint camphor
p-Menthan-3-ol
Racementhol
Racementholum
Racementol
THERAPEUTIC MINERAL ICE
TIXYLIX DECONGESTANT INH
U.S.p. menthol
VOCALZONE
|
|
41 |
|
Prucalopride |
Approved |
Phase 2 |
|
179474-81-8 |
3052762 |
Synonyms:
4-Amino-5-chloro-N-(1-(3-methoxypropyl)-4-piperidinyl)-2,3-dihydro-1-benzofuran-7-carboxamide
4-Amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboximidate
Motegrity®|R-093877|R-108512|Resolor®
Prucaloprida
PRUCALOPRIDE
R-093877
|
R-093877Prucalopride
R-108512
Resolor
Resotran
Resotrans
|
|
42 |
|
Modafinil |
Approved, Investigational |
Phase 2 |
|
68693-11-8 |
4236 |
Synonyms:
2-((Diphenylmethyl)sulfinyl)acetamide
2-((R)-(Diphenylmethyl)sulfinyl)acetamide
2-[(Diphenylmethyl)sulphinyl]acetamide
Alertec
Armodafinil
Benzhydrylsulfinylacetamide
CEP-1538
CEPA brand OF modafinil
Cephalon brand OF modafinil
Cephalon brand OF modafinil, reformulated
CRC-40476
CRL-40476
Dea No. 1680
DEP-1538
Draxis brand OF modafinil
Lafon brand OF modafinil
Merckle brand OF modafinil
Modafinil
|
Modafinil [Usan:Inn]
MODAFINIL CIV
Modafinilo
Modafinilo [Spanish]
Modafinilum
Modafinilum [Latin]
Moderateafinil
Modiodal
Nourypharma brand OF modafinil
Nuvigil
Provigil
Provigil®
R Modafinil
R-Modafinil
Sparlon
THN102 COMPONENT MODAFINIL
THN-102 COMPONENT MODAFINIL
Vigil
|
|
43 |
|
Carboplatin |
Approved |
Phase 2 |
|
41575-94-4 |
10339178 38904 |
Synonyms:
Blastocarb
Carboplat
CARBOPLATIN
Carboplatine
Carboplatino
Carbosin
Carbotec
Cbdca
CIS-(1,1-CYCLOBUTANEDICARBOXYLATO)DIAMMINEPLATINUM(II)
CIS-DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM
CIS-DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM(II)
|
Ercar
JM 8
JM8
JM-8
Nealorin
Neocarbo
NSC-201345
NSC-241240
PARAPLATIN
Paraplatin-AQ
Ribocarbo
|
|
44 |
|
Paclitaxel |
Approved, Vet_approved |
Phase 2 |
|
33069-62-4 |
36314 |
Synonyms:
(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5Β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5Β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7 Epi taxol
7-Epipaclitaxel
7-Epi-paclitaxel
7-epipaclitaxel|Abraxane® (albumin-bound suspension)|Taxol®
7-Epitaxol
7-Epi-taxol
ABI-007
ABRAXANE
Anzatax
BMS 181339-01
BMS-181339-01
Bris taxol
CAPXOL
CYCLOPAX
DHP 107
|
EBETAXEL
Epitaxol
GENETAXYL
GENEXOL
INTAXEL
LIPOPAC
MBT 0206
MITOTAX
NK 105
NSC-125973
Onxol
PACITAXEL
PACLITAXEL
Paclitaxel, (4 alpha)-isomer
Paxceed
Paxene
PLAXICEL
Praxel
QW-8184
TAXALBIN
TAXOL
TAXOL 100
Taxol a
Taxol, bris
Vascular Wrap
Xorane
YEWTAXAN
|
|
45 |
|
Lidocaine |
Approved, Vet_approved |
Phase 2 |
|
137-58-6 |
3676 |
Synonyms:
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
a-Diethylamino-2,6-dimethylacetanilide
ALGRX 3268
ALGRX-3268
ALPHACAINE
alpha-Diethylamino-2,6-dimethylacetanilide
ANESTACON
Astrazeneca brand OF lidocaine
Dalcaine
Dentipatch
Dilocaine
EMBOLEX
IONTOCAINE
Jenapharm brand OF lidocanine hydrochloride
L-Caine
Lidocaina
Lidocaína
LIDOCAINE
Lidocaine carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
|
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
LIDOCATON
Lidoderm
LIDOPEN
Lignocaine
LIGNOCAINE HCL
LIGNOSTAB
LMX 4
Novocol brand OF lidocaine hydrochloride
NSC-40030
Octocaine
ORAQIX
Strathmann brand OF lidocaine hydrochloride
VAGISIL
Xylesthesin
Xylocaine
Xylocaine®
Xylocitin
XYLODASE
Xyloneural
XYLOTOX
ZTLIDO
Α-diethylamino-2,6-dimethylacetanilide
|
|
46 |
|
Glycerin |
Approved, Investigational |
Phase 2 |
|
56-81-5 |
753 |
Synonyms:
(2,5-Dihydroxyphenyl)-acetate
(2,5-Dihydroxyphenyl)-acetic acid
(2E)-2-Butenedioate
(2E)-2-Butenedioic acid
(2E)-But-2-enedioate
(2E)-But-2-enedioic acid
(e)-2-Butenedioate
(e)-2-Butenedioic acid
1,2,3-Propanetriol
1,2,3-Trihydroxypropane
2-(3,6-DIHYDROXYPHENYL)acetate
2-(3,6-DIHYDROXYPHENYL)acetIC ACID
2-(e)-Butenedioate
2-(e)-Butenedioic acid
2,5-Dihydroxy-alpha-toluate
2,5-Dihydroxy-alpha-toluic acid
2,5-Dihydroxy-a-toluate
2,5-Dihydroxy-a-toluic acid
2,5-Dihydroxy-benzeneacetate
2,5-Dihydroxy-benzeneacetic acid
2,5-Dihydroxyphenylacetate
2,5-Dihydroxyphenylacetic acid
Acid, homogentisic
Alcapton
Allomaleate
Allomaleic acid
alpha-delta-Glucopyranuronic acid
alpha-delta-Glucuronic acid
alpha-D-Glucopyranuronic acid
alpha-D-Glucuronic acid
Ammonium fumarate
Boletate
Boletic acid
Bulbold
Concentrated glycerin
Cristal
D-(+)-Glucuronate
D-(+)-Glucuronic acid
delta-(+)-Glucuronate
delta-(+)-Glucuronic acid
delta-Glucuronate
D-Glucuronate
e 422
e297
Emery 916
FC 33
Fumarate
Fumarsaeure
Furamag
GCU
GlcAa
GlcAalpha
|
Glucosiduronate
Glucosiduronic acid
Glucuronate
Glucuronic acid
Glyceol opthalgan
Glycerin
Glycerin, anhydrous
Glycerin, concentrated
Glycerin,anhydrous
Glycerine
glycérine
Glycerinum
Glyceritol
Glycerol
glycérol
Glycerolum
Glycyl alcohol
Glyrol
Glysanin
Glyzerin
Gro
Homogentisate
Homogentisate acid
Homogentisinate
Homogentisinic acid
IFP
Incorporation factor
Lichenate
Lichenic acid
Mackstat H 66
Mafusol
Magnesium fumarate
Melanic acid
Monoctanoin component D
Oelsuess
Ölsüß
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Sodium fumarate
trans-1,2-Ethylenedicarboxylate
trans-1,2-Ethylenedicarboxylic acid
trans-2-Butenedioate
trans-2-Butenedioic acid
trans-But-2-enedioate
trans-But-2-enedioic acid
trans-Butenedioate
trans-Butenedioic acid
Trihydroxypropane
Tryhydroxypropane
|
|
47 |
|
Capsaicin |
Approved |
Phase 2 |
|
404-86-4 |
1548943 |
Synonyms:
(e)8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide(8CL)
8 Methyl N vanillyl 6 nonenamide
8-Methyl-N-vanillyl-6-nonenamide
Alacan brand OF capsaicin
ALGRX 4975
ALGRX-4975
Antiphlogistine rub a-535 capsaicin
Axsain
CAPSAICIN
Capsaicina
Capsaicine
Capsicum farmaya
Capsidol
Capsin
Capzasin
Carter horner brand OF capsaicin
Centrum brand OF capsaicin
e-Capsaicin
Elan brand OF capsaicin
epsilon-Capsaicin
FEMA NO. 3404
Flemming brand OF capsaicin
|
Gelcen
Isodecenoate
Isodecenoate vanillylamide
Isodecenoic acid
Isodecenoic acid vanillylamide
Katrum
Link brand OF capsaicin
Medicis brand OF capsaicin
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide
NGX-1998
NGX-4010
NSC-56353
QUTENZA
Qutenza®
Smaller brand OF capsaicin
Styptysat
Thompson brand OF capsaicin
trans-8-Methyl-N-vanillyl-6-nonenamide
Transacin
Vinas brand OF capsaicin
Zacin
Zostrix
ZOSTRIX HP
|
|
48 |
|
Amifostine |
Approved, Investigational |
Phase 2 |
|
20537-88-6 |
2141 |
Synonyms:
Acid, aminopropylaminoethylthiophosphoric
Alza brand OF amifostine
Amifostina
AMIFOSTINE
Amifostine alza brand
Amifostine anhydrous
Amifostine disodium salt
AMIFOSTINE DISULFIDE
Amifostine essex brand
Amifostine ethiofos
Amifostine lilly brand
Amifostine monohydrate
Amifostine monohydrochloride
Amifostine schering-plough brand
Amifostine trihydrate
Amifostinum
Aminopropyl aminoethylthiophosphate
Aminopropylaminoethyl thiophosphate
Aminopropylaminoethylthiophosphate
Aminopropylaminoethylthiophosphoric acid
Anhydrous, amifostine
Anhydrous, ethiofos
|
Apaetp
Disodium salt, amifostine
Essex brand OF amifostine
Ethanethiol, 2-((3-aminopropyl)amino)-, dihydrogen phosphate (ester), trihydrate
Ethiofos
Ethiofos anhydrous
Ethyol
Gammaphos
Lilly brand OF amifostine
Monohydrate, amifostine
Monohydrochloride, amifostine
NSC-296961
S-(N-(3-Aminopropyl)-2-aminoethyl)thiophosphoric acid
SAPEP
Schering plough brand OF amifostine
Schering-plough brand OF amifostine
Trihydrate, amifostine
US bioscience brand OF amifostine
WR-1065
WR-2721
WR-2721 TRIHYDRATE
YM-08310
|
|
49 |
|
Piperine |
Investigational |
Phase 1, Phase 2 |
|
94-62-2 |
638024 |
Synonyms:
((1-5-(1,3)-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)piperidine
(1-(5-(1,3)-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)piperidine
(e,e)-1-Piperoylpiperidine
1-[(2E,4E)-5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine
1-[(2E,4E)-5-(1,3-Benzodioxol-5-yl)-2,4-pentadienoyl]piperidine
1-Piperoyl-(e,e)-piperidine
1-Piperoylpiperidine
1-Piperoyl-piperidine
Bioperine
FEMA 2909
FEMA NO. 2909
|
N-(e,e)-Piperoyl-piperidine
N-[(e,e)-Piperoyl]piperidine
N-Ee-piperoyl-piperidine
NSC-21727
Piperin
PIPERINE
Piperine, (e,e)-isomer
Piperine, (e,Z)-isomer
Piperine, (Z,e)-isomer
Piperine, (Z,Z)-isomer
|
|
50 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 1, Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 413)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Does Opioid Induced Swallowing Difficulty Lead to Elevated Risk for Pulmonary Aspiration? |
Completed |
NCT01495377 |
Phase 4 |
Remifentanil;Placebo;Technetium |
2 |
Effect of Pharyngeal Inhibition Induced by Repetitive Transcranial Stimulation in Post Stroke Dysphagia |
Completed |
NCT01081444 |
Phase 4 |
|
3 |
Evaluation of Two Different Thickening Products in Patients With Dysphagia |
Completed |
NCT01651975 |
Phase 4 |
|
4 |
Neuromuscular Electroestimulation and Respiratory Muscle Training in the Management of Dysphagia of Subacute Stroke Patients |
Completed |
NCT02473432 |
Phase 4 |
|
5 |
Efficacy of IV vs Oral Administration of Acetaminophen for Pain Control Following Tonsillectomy With or Without Adenoidectomy |
Completed |
NCT01721486 |
Phase 4 |
IV acetaminophen;PO acetaminophen |
6 |
Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft |
Completed |
NCT01507207 |
Phase 4 |
|
7 |
Impact of Single Dose Perioperative Steroids on Dysphagia Following Anterior Cervical Spine Surgery: A Randomized, Prospective, Double-Blind Study |
Recruiting |
NCT03711474 |
Phase 4 |
Dexamethasone;Saline |
8 |
The Effect of Oral Buspirone Hydrochloride on Esophageal Motility, Bolus Transit and Symptoms of Dysphagia, in Patients With Poor Esophageal Motility: A Randomized, Double-blind, Placebo Controlled, Cross-over Trial With HRiM |
Recruiting |
NCT05629325 |
Phase 4 |
Buspirone Hydrochloride 10 MG;Placebo |
9 |
Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills |
Terminated |
NCT03588806 |
Phase 4 |
Xtampza ER (oxycodone) |
10 |
A Randomized Placebo Controlled Trial of Low Dose Angiotensin Converting Enzyme Inhibitor to Prevent Pneumonia in Older People Who Require Tube Feeding Because of Neurological Dysphagia |
Terminated |
NCT02358642 |
Phase 4 |
Angiotensin converting enzyme inhibitor (Lisinopril);Placebo |
11 |
Impact of Early Percutaneous Tracheostomy on the Incidence of Swallowing Dysfunction in Critically Ill Patients on Mechanical Ventilation. A Randomized Clinical Trial |
Unknown status |
NCT01268423 |
Phase 3 |
|
12 |
The Comparison of Value of Brachytherapy and Endoscopic Stenting With SEMS in Palliative Treatment of Dysphagia Resulting From Adenocarcinoma of the Esophago-Gastric Junction |
Unknown status |
NCT01786278 |
Phase 2, Phase 3 |
|
13 |
A Randomised Controlled Trial of Dysphagia Therapies for Swallowing Disorders Following Stroke. |
Completed |
NCT00257764 |
Phase 2, Phase 3 |
|
14 |
The Effects of Intraoperative Local and Systemic Corticosteroid Administration on Postoperative Dysphagia After Anterior Cervical Fusion |
Completed |
NCT03311425 |
Phase 3 |
Methylprednisolone;Dexamethasone |
15 |
A Randomized, Prospective Trial of Electrosurgical Incision Followed by Rabeprazole Versus Bougie Dilation Followed by Rabeprazole of Symptomatic Lower Esophageal (Schatzki's) Rings |
Completed |
NCT00204750 |
Phase 2, Phase 3 |
|
16 |
A Randomised Phase III Study in Advanced Oesophageal Cancer to Compare Quality of Life and Palliation of Dysphagia in Patients Treated With Radiotherapy vs ChemoRadiotherapy. |
Completed |
NCT00193882 |
Phase 3 |
Cisplatin;5-Fluorouracil |
17 |
Study for the Evaluation of the Impact of HEPILOR on the Possible Delay in the Development of Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy on the Breast/Thoracic Wall and Lymph Node Drainage. |
Completed |
NCT03997188 |
Phase 3 |
|
18 |
Muscle Preservation and Swallow Function Following Radiotherapy: A Dose Response Study |
Completed |
NCT01279837 |
Phase 2, Phase 3 |
|
19 |
A Randomized Controlled Trial of NMES vs. Traditional Dysphagia Therapy After Stroke |
Completed |
NCT01279824 |
Phase 2, Phase 3 |
|
20 |
The Effect of Intravenous Non-steroidal Anti-inflammatory Drugs and Intravenous Corticosteroids on the Likelihood of Dysphagia and Dysphonia Following Anterior Cervical Discectomy and Fusion |
Not yet recruiting |
NCT04650893 |
Phase 3 |
Intravenous Ketorolac;Intravenous Dexamethasone;Placebo |
21 |
Efficacy and Safety of Onabotulinum Toxin A (Botox) Injections in the Upper Esophageal Sphincter for the Treatment of Pharyngo-esophageal Dysphagia Due to Cricopharyngeal Dysfunction- A Randomized Double Blinded Placebo Controlled Trial |
Not yet recruiting |
NCT04695600 |
Phase 2, Phase 3 |
Botulinum Toxin Type A Injection [Botox] |
22 |
The Study of Efficacy on Low Dose Nicergoline in Dysphagia Patients Compares With High Dose Nicergoline. |
Not yet recruiting |
NCT05551182 |
Phase 3 |
Nicergoline |
23 |
Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia |
Terminated |
NCT01971320 |
Phase 3 |
|
24 |
Effect of Intravenous Corticosteroid Injections on Dysphagia After Anterior Cervical Spine Surgery: a Randomized, Double-blind, Placebo-controlled Study |
Terminated |
NCT02266797 |
Phase 3 |
Dexamethasone |
25 |
Effectiveness of Acupuncture-like Transcutaneous Nerve Stimulation (ALTENS) in Improving Dysphagia and Associated Symptoms of Chemotherapy and/or Intensity Modulated Radiation Therapy (IMRT) for Head and Neck Cancers: A Pilot Study |
Unknown status |
NCT01697891 |
Phase 1, Phase 2 |
|
26 |
Phase 2 Study of rTMS on Poststroke Dysphagia |
Unknown status |
NCT02090231 |
Phase 2 |
|
27 |
Swallowing Rehabilitation of Dysphagic Tracheostomized Patients Under Mechanical Ventilation at Intensive Care Unit |
Unknown status |
NCT01496924 |
Phase 2 |
|
28 |
Randomized Phase II Trial: Swallowing Speech Pathology Intervention During Radiochemotherapy on Patients With Head and Neck Cancer |
Completed |
NCT02075385 |
Phase 2 |
|
29 |
Effect of Oral Menthol on the Swallow Response of Patients With Oropharyngeal Dysphagia Associated With Neurological Diseases and Aging |
Completed |
NCT03050957 |
Phase 2 |
|
30 |
Effect of Natural Agonists of TRPV1 in the Treatment of Functional Oropharyngeal Dysphagia in Neurological Diseases and the Elderly: Piperine |
Completed |
NCT01383694 |
Phase 1, Phase 2 |
Piperine |
31 |
Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts |
Completed |
NCT00773227 |
Phase 2 |
|
32 |
Efficacy of Functional Electrical Stimulation in Dysphagia of Nasopharyngeal Cancer Post Radiotherapy |
Completed |
NCT00815087 |
Phase 2 |
|
33 |
Effects of Age and Age-Related Diseases on Swallowing |
Completed |
NCT00038350 |
Phase 2 |
|
34 |
Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer |
Completed |
NCT01032928 |
Phase 2 |
|
35 |
Treatment of Dysphagia Using the Mendelsohn Maneuver |
Completed |
NCT00592761 |
Phase 1, Phase 2 |
|
36 |
Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot Study |
Completed |
NCT03244553 |
Phase 2 |
Prucalopride |
37 |
Pilot Study of Transcranial Direct Current Stimulation for Facilitating Swallowing Improvement After an Acute Unilateral Hemispheric Infarction |
Completed |
NCT01132066 |
Phase 1, Phase 2 |
|
38 |
Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia |
Completed |
NCT01085903 |
Phase 2 |
Modafinil;Placebo |
39 |
A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia |
Completed |
NCT00376506 |
Phase 2 |
|
40 |
Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy |
Completed |
NCT00332865 |
Phase 1, Phase 2 |
|
41 |
Induction of Volitional Swallowing in Chronic Dysphagia Post Stroke: A Novel Mechanism-Based Intervention |
Completed |
NCT00306501 |
Phase 2 |
|
42 |
A Phase 2 Study to Evaluate the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) in the Reduction of Dysphagia in Patients Receiving Concurrent Chemoradiotherapy Followed by Consolidation Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) |
Completed |
NCT00094861 |
Phase 2 |
Palifermin;Placebo;Paclitaxel;Carboplatin |
43 |
Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis-Related Pain During the Treatment of Lung Cancer |
Completed |
NCT01262560 |
Phase 2 |
Manuka honey in liquid form;Manuka honey in lozenge form;Standard supportive care |
44 |
Tongue Pressure Profile Training for Dysphagia Post Stroke |
Completed |
NCT01370083 |
Phase 2 |
|
45 |
Effect of Afferent Oropharyngeal Pharmacological and Electrical Stimulation on Swallow Response and on Activation of Human Cortex in Stroke Patients With Oropharyngeal Dysphagia (OD). A Randomized Controlled Trial. |
Completed |
NCT01777672 |
Phase 2 |
|
46 |
Effectiveness of a New Neuromuscular Electrical Stimulation (NMES) Treatment Technique (VitalStim® Therapy) in the Management of Young Infants With Severe Dysphagia: a Prospective Pilot Study |
Completed |
NCT01723358 |
Phase 2 |
|
47 |
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial |
Completed |
NCT02927691 |
Phase 2 |
|
48 |
A Multi-Center, Double-Blind, Randomized Placebo-Controlled Investigation of Autologous Muscle Derived Cells (AMDC) for the Treatment of Tongue Dysphagia Resulting From the Treatment of Head and Neck Cancer |
Recruiting |
NCT05421689 |
Phase 1, Phase 2 |
|
49 |
Impacts of an Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model to Prevent Swallowing Disorders in Patients Treated With Chemoradiotherapy for Head and Neck Cancer |
Not yet recruiting |
NCT05621889 |
Phase 1, Phase 2 |
|
50 |
A Multicenter, Randomized, Double-blind, Double-dummy, Positive Drug Parallel Controlled Phase II Clinical Trial to Evaluate Efficacy and Safety of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis |
Not yet recruiting |
NCT05604261 |
Phase 2 |
Anaprazole sodium 40 mg;Anaprazole sodium 60 mg;Rabeprazole sodium 20 mg |
|